PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1477109
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1477109
Transcutaneous Electrical Nerve Stimulation Market size was valued at USD 435 Million in 2023, expanding at a CAGR of 4.1% from 2024 to 2032.
One non-invasive treatment for pain management is transcutaneous electrical nerve stimulation or TENS. Through the use of electrodes applied to the skin, a small, battery-operated device sends low-voltage electrical currents to particular body parts. These electrical currents are hypothesized to lessen pain perception by interfering with the brain's ability to receive pain signals. TENS is frequently used to treat both acute and chronic pain, including menstrual pain, arthritis, neuropathy, and back pain. When used appropriately and under a healthcare provider's supervision, it is usually regarded as safe.
Transcutaneous Electrical Nerve Stimulation Market- Market Dynamics
Increasing the ageing population to propel market demand
An increasing proportion of the population is suffering from chronic pain associated with diseases like osteoarthritis as a result of population ageing in many countries. TENS units provide a practical at-home pain relief solution. For instance, according to the news published by UNFPA, the population of the world is ageing and living longer. Adapting to and organizing for this significant demographic shift is one of the biggest societal problems of the twenty-first century. India has the largest proportion of youth, yet the country's ageing population is ageing quickly. By 2050, there will be an astounding 347 million senior people (those 60 and older) worldwide, up from the present 153 million. This change in the population is not just a number; rather, it represents an unprecedented social revolution with far-reaching effects.
Transcutaneous Electrical Nerve Stimulation Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.1% over the forecast period (2024-2032)
Based on product type, the Portable TENS segment is expected to grow at the highest CAGR during the forecast period
Based on application segmentation, the acute pain segment is expected to lead the market over the projected period
Based on region, North America was the leading revenue generator in 2023
The Global Transcutaneous Electrical Nerve Stimulation Market is segmented based on Product Type, Application, End-Use, and Region.
Based on the product type, the market is categorized into Portable TENS and Table Top TENS. The Portable TENS segment is expected to grow at the highest CAGR during the forecast period. The ease of on-the-go pain treatment therapy is provided by portable TENS devices. One may use them at home, at work, or on the go because they are small, light, and frequently run on batteries.
Based on the application, the industry is divided into Chronic Pain and Acute Pain. The Acute Pain segment is expected to lead the market over the projected period. Sports-related injuries, medical conditions, trauma, and surgery are the main causes of this kind of pain. The danger of injury is rising as more people engage in sports and leisure activities. For instance, nearly 3.5 million injuries among children and teens are recorded annually in the United States, according to Stanford Children's Health.
Transcutaneous Electrical Nerve Stimulation Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market during the forecast period. The early release of new TENS devices, the existence of important players, and significant government funding for the creation of cutting-edge medical equipment are all contributing to the regional market's expansion. Furthermore, it is anticipated that the market will rise due to consumers' high purchasing power, rising adoption of cutting-edge technology, and inventive medical equipment.
The key players operating in the market include Boston Scientific, Medtronic, Abbott, Cyberonics, DJO LLC., Nevro Corp., NeuroMetrix, Uroplasty, Cogentix Medical and NeuroPace. These players adopted several strategies to capture the maximum market share such as product launch, acquisition, expansion and others.
GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Boston Scientific
Medtronic
Abbott
Cyberonics
DJO LLC.
Nevro Corp.
NeuroMetrix
Uroplasty
Cogentix Medical
NeuroPace